Predictive formula for acute liver failure is useful for predicting the prognosis of patients with acute-on-chronic liver failure

Aim The prognosis of acute‐on‐chronic liver failure (ACLF) is extremely poor in comparison to acute liver failure (ALF). We aimed to establish methods for the early diagnosis of ACLF and its severity to identify the patients with a poor prognosis. Methods The laboratory data at admission of 30 ACLF...

Full description

Saved in:
Bibliographic Details
Published inHepatology research Vol. 46; no. 5; pp. 459 - 467
Main Authors Kakisaka, Keisuke, Kataoka, Kojiro, Kuroda, Hidekatsu, Takikawa, Yasuhiro
Format Journal Article
LanguageEnglish
Published Netherlands Blackwell Publishing Ltd 01.04.2016
Subjects
Online AccessGet full text
ISSN1386-6346
1872-034X
1872-034X
DOI10.1111/hepr.12577

Cover

More Information
Summary:Aim The prognosis of acute‐on‐chronic liver failure (ACLF) is extremely poor in comparison to acute liver failure (ALF). We aimed to establish methods for the early diagnosis of ACLF and its severity to identify the patients with a poor prognosis. Methods The laboratory data at admission of 30 ACLF and 46 ALF patients were compared. Three established prognosis prediction models (Model for End‐Stage Liver Disease [MELD]; MELD modified by serum sodium concentration, [MELD‐Na]; and the Japan hepatic encephalopathy prediction model [J‐HEPM]) were assessed using area under the receiver–operator curve (AUROC) values. Results No significant difference was found in the laboratory data of the two patient groups. J‐HEPM was able to predict the outcome of the ACLF subjects (AUROC = 0.93). Conclusion Although ACLF could not be differentially diagnosed from ALF at admission from the laboratory data alone, the J‐HEPM effectively predicted the prognosis of liver failure in patients with ACLF. These findings indicate that ACLF patients with high J‐HEPM scores require earlier and more intensive care than ALF patients.
Bibliography:ArticleID:HEPR12577
istex:AD8C6D3295CE3C7CAD15A3F283A9AD1AA608DC5D
Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan to the Intractable Hepatobiliary Diseases Study Group - No. 25461008
ark:/67375/WNG-K2D1G7G2-H
There are no conflicts of interest with regard to this work.
Conflict of interest
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1386-6346
1872-034X
1872-034X
DOI:10.1111/hepr.12577